Therefore, we sought to identify potent and selective antagonists to pharmacologically characterize the role of MRGPRX2 in relevant in vitro, ex vivo, and in vivo models to support further investigation of the role of this mast cell receptor in skin disorders. The gene discussed is MRGPRX2; the disease is skin disorder.